Scientists map the genetic landscape of drug resistance in cancers

All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential effective second-line therapies.

Simple pre-surgical protocol can help prevent dangerous post-surgical infections

A new study published today in the American Journal of Infection Control (AJIC) demonstrates the use of a simple pre-surgical infection prevention protocol to prevent

March 28, 2024

NCCN guidelines establish an equitable standard of care for cancer outcomes

Today, the National Comprehensive Cancer Network® (NCCN®)-;an alliance of leading cancer centers-;convened a policy summit to examine how geography impacts cancer outcomes.

June 16, 2023

China NMPA approves MSD’s KEYTRUDA for NSCLC stages

The approval marks the first indication of MSD’s KEYTRUDA in the earlier stages of NSCLC in China. Credit: JHVEPhoto/Shutterstock. China National Medical Products Administration (NMPA)

December 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.